235 related articles for article (PubMed ID: 28355493)
1. pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies.
Gil JP; Krishna S
Expert Rev Anti Infect Ther; 2017 Jun; 15(6):527-543. PubMed ID: 28355493
[TBL] [Abstract][Full Text] [Related]
2. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
3. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
4. Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
Goomber S; Mishra N; Anvikar A; Yadav CP; Valecha N
Infect Genet Evol; 2018 Sep; 63():285-290. PubMed ID: 29842979
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
[TBL] [Abstract][Full Text] [Related]
7. Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.
Mbaye A; Dieye B; Ndiaye YD; Bei AK; Muna A; Deme AB; Yade MS; Diongue K; Gaye A; Ndiaye IM; Ndiaye T; Sy M; Diallo MA; Badiane AS; Ndiaye M; Seck MC; Sy N; Koita O; Krogstad DJ; Nwakanma D; Ndiaye D
Malar J; 2016 Aug; 15(1):433. PubMed ID: 27562216
[TBL] [Abstract][Full Text] [Related]
8. Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
Legrand E; Yrinesi J; Ekala MT; Péneau J; Volney B; Berger F; Bouchier C; Bertani S; Musset L; Meynard JB; Mercereau-Puijalon O
Antimicrob Agents Chemother; 2012 Mar; 56(3):1382-9. PubMed ID: 22232280
[TBL] [Abstract][Full Text] [Related]
9. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
Nsobya SL; Dokomajilar C; Joloba M; Dorsey G; Rosenthal PJ
Antimicrob Agents Chemother; 2007 Aug; 51(8):3023-5. PubMed ID: 17562798
[TBL] [Abstract][Full Text] [Related]
10.
Montenegro M; Neal AT; Posada M; De Las Salas B; Lopera-Mesa TM; Fairhurst RM; Tobon-Castaño A
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947476
[TBL] [Abstract][Full Text] [Related]
11. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.
Ng CL; Siciliano G; Lee MC; de Almeida MJ; Corey VC; Bopp SE; Bertuccini L; Wittlin S; Kasdin RG; Le Bihan A; Clozel M; Winzeler EA; Alano P; Fidock DA
Mol Microbiol; 2016 Aug; 101(3):381-93. PubMed ID: 27073104
[TBL] [Abstract][Full Text] [Related]
13. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.
Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581
[TBL] [Abstract][Full Text] [Related]
15. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa.
Sisowath C; Ferreira PE; Bustamante LY; Dahlström S; Mårtensson A; Björkman A; Krishna S; Gil JP
Trop Med Int Health; 2007 Jun; 12(6):736-42. PubMed ID: 17550470
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
[TBL] [Abstract][Full Text] [Related]
17. pfmdr1 mutations in imported African Plasmodium falciparum isolates.
Dippmann AK; Bienzle U; Harms G; Mockenhaupt FP
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1148-50. PubMed ID: 18513774
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
[TBL] [Abstract][Full Text] [Related]
19. Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport.
Calçada C; Silva M; Baptista V; Thathy V; Silva-Pedrosa R; Granja D; Ferreira PE; Gil JP; Fidock DA; Veiga MI
mBio; 2020 Dec; 11(6):. PubMed ID: 33262257
[TBL] [Abstract][Full Text] [Related]
20. Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.
Gadalla NB; Adam I; Elzaki SE; Bashir S; Mukhtar I; Oguike M; Gadalla A; Mansour F; Warhurst D; El-Sayed BB; Sutherland CJ
Antimicrob Agents Chemother; 2011 Nov; 55(11):5408-11. PubMed ID: 21896916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
